US EditionPublished • loading... • Updated
Haemonetics Corporation (NYSE:HAE) Given Consensus Rating of “Moderate Buy” by Analysts
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Haemonetics Corporation (NYSE:HAE) Given Consensus Rating of “Moderate Buy” by Analysts
Haemonetics Corporation (NYSE:HAE – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and two have given […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
